These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6352047)

  • 1. Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline.
    Bonuso S; Di Stasio E; Barone P; Steardo L
    Cephalalgia; 1983 Aug; 3 Suppl 1():175-8. PubMed ID: 6352047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergot derivatives in the prophylaxis of migraine: a multicentric study with a timed-release dihydroergotamine formulation.
    Martucci N; Manna V; Mattesi P; Troiani G; Manzoni GC; Lanfranchi M; Bono G; Micieli G
    Cephalalgia; 1983 Aug; 3 Suppl 1():151-5. PubMed ID: 6352046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of migraine and tension headaches with amitriptyline (author's transl)].
    Pluvinage R
    Sem Hop; 1978 Sep 8-15; 54(21-24):713-6. PubMed ID: 213837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of migraine attacks through the use of dihydroergotamine.
    Neuman M; Demarez JP; Harmey JL; Le Bastard B; Cauquil J
    Int J Clin Pharmacol Res; 1986; 6(1):11-3. PubMed ID: 3514491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive therapy with programmed-release dihydroergotamine in headache in childhood].
    Conigliaro S; Rosà R; Filippi MC; Merati L; Taddei MT
    Minerva Med; 1987 Jul; 78(14):1063-4. PubMed ID: 3496562
    [No Abstract]   [Full Text] [Related]  

  • 6. Planned release dihydroergotamine in common migraine and "tension-vascular headache": multicentre clinical trial.
    Fontanari D; Perulli L; Conte F; Tambato E; Toso V; Zanetti R
    Cephalalgia; 1983 Aug; 3 Suppl 1():189-91. PubMed ID: 6352048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine.
    D'Alessandro R; Gamberini G; Lozito A; Sacquegna T
    Cephalalgia; 1983 Aug; 3 Suppl 1():156-8. PubMed ID: 6616598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine skin test in cluster headache: effects of dihydroergotamine with timed release.
    Giacovazzo M; Romiti A; Martelletti P; Gallo MF; Megale G
    Cephalalgia; 1983 Aug; 3 Suppl 1():171-4. PubMed ID: 6616600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of migraine and mixed headache. A randomized controlled study.
    Mathew NT
    Headache; 1981 May; 21(3):105-9. PubMed ID: 7021472
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
    Scott AK
    Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial.
    Frediani F; Grazzi L; Zanotti A; Mailland F; Zappacosta BM; Bussone G
    Cephalalgia; 1991 Jul; 11(3):117-21. PubMed ID: 1909603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of morning migraine. Clinical and biokinetic correlation of programmed-release dihydroergotamine].
    Aylward M; Chazot G; Maddock J; Schott B
    Presse Med; 1984 Jun; 13(26):1617-9. PubMed ID: 6234558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind study of the effects of amitriptyline and of a combination of amitriptyline and lithium on patients with chronic primary headache].
    Casacchia M; Cerbo R; Corona R; Boni B
    Riv Neurol; 1981; 51(2):114-23. PubMed ID: 7017887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Migraine prevention with dihydroergotamine].
    Heuser B; Middendorf E
    Fortschr Med; 1985 Nov; 103(41):966-70. PubMed ID: 3905548
    [No Abstract]   [Full Text] [Related]  

  • 15. Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo.
    Andersson PG; Jespersen LT
    Cephalalgia; 1986 Mar; 6(1):51-4. PubMed ID: 3516408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroergotamine: role in the treatment of migraine.
    Schürks M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache.
    Couch JR;
    Headache; 2011 Jan; 51(1):33-51. PubMed ID: 21070231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amitriptyline in therapy of chronic tension headache].
    Göbel H; Hamouz V; Hansen C; Heininger K; Hirsch S; Lindner V; Heuss D; Soyka D
    Nervenarzt; 1994 Oct; 65(10):670-9. PubMed ID: 7808565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo].
    Pfaffenrath V; Diener HC; Isler H; Meyer C; Scholz E; Taneri Z; Wessely P; Zaiser-Kaschel H; Haase W; Fischer W
    Nervenarzt; 1993 Feb; 64(2):114-20. PubMed ID: 8450893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.